Prostaglandin E2-biotinamide CAS: 363-24-6 (unconjugated)
MF: C35H58N4O6S
MW: 662.9
A biotinylated PGE2 derivative designed to detect PGE2 bound in complexes.

Prostaglandin E2-biotinamide (CAS 363-24-6 (unconjugated))

  • bvseo_sdk, java_sdk, bvseo-3.2.0
  • CLOUD, getAggregateRating, 162ms
  • REVIEWS, PRODUCT
  • bvseo-msg: The resource to the URL or file is currently unavailable.;
Anwendungen Prostaglandin E2-biotinamide is A biotinylated PGE2 derivative designed to detect PGE2 bound in complexes
CAS Nummer: 363-24-6 (unconjugated)
Molekulargewicht: 662.9
Summenformel: C35H58N4O6S
Ergänzende Informationen: This is classified as a Dangerous Good for transport and may be subject to additional shipping charges.
Ausschließlich für Forschungszwecke. Nicht Geeignet für Verwendung in Diagnostik oder Therapie.
* Schauen Sie auf das Analysezertifikat (CoA), um die genauen Daten (inkl. Wassergehalt) Ihrer Produktionscharge (Lot) zu sehen.

Prostaglandin E2-biotinamide is a biotinylated Prostaglandin E2 (PGE2; sc-201225) derivative that is designed to allow PGE2 to be detected in complexes with transmembrane receptors and/or nucleic acid or protein binding partners - an incredibly useful tool in the general elucidation of the mechanism of action of Prostaglandins. PGE2 is the most physiologically abundant eicosanoid, which is produced predominantly from arachidonic acid (sc-200770) by COX and PGES, and exists at some level in nearly all cell types. PGE2 acts on four different receptors termed EP1 through EP4 yielding an astounding array of biological effects; including: potent vasodialation, smooth muscle relaxation, both anti- and proinflammatory activities, stimulates bone resorption, synergizes with LTB4, facilitates replication of AIDS virus, regulates sleep/wake cycle, demonstrates thermoregulatory action in the CNS, induces LHRH release from rat median eminence, demonstrates a protective effect on gastric mucosa, and regulates renal hemodynamics and sodium excretion.


Literaturhinweise

1. Richardson, P.D., et al. 1976. Br. J. Pharmacol. 57: 581-588. PMID: 963344
2. Raisz, L.G., et al. 1977. Nature. 267: 532-534. PMID: 876371
3. Miller, T.A., 1983. Am. J. Physiol. 245: G601-G623. PMID: 6195926
4. Kuno, S., et al. 1986. Proc. Natl. Acad. Sci. U.S.A. 83: 3487-3490. PMID: 3010301
5. Kuno, S., et al. 1986. Proc. Natl. Acad. Sci. U.S.A. 83: 2682-2683. PMID: 3458226
6. Archer, C.B., et al. 1987. Prostaglandins. 33: 799-805. PMID: 2823313
7. Hayaishi, O. 1988. J. Biol. Chem. 263: 14593-14596. PMID: 3049580
8. Raud, J., et al. 1988. Proc. Natl. Acad. Sci. U.S.A. 85: 2315-2319. PMID: 2451246
9. Long, C.R., et al. 1990. Prostaglandins. 40: 591-601. PMID: 2093936
10. Christman, J.W., et al. 1991. Prostaglandins. 41: 251-262. PMID: 1852897
11. Gerozissis, K., et al. 1991. Prostaglandins. 41: 345-357. PMID: 1871376

Formulierung :
A solution in ethanol
Aggregatzustand :
Liquid
LAGERUNG: :
Store at -20° C
Ausschließlich für Forschungszwecke. Nicht Geeignet für Verwendung in Diagnostik oder Therapie.
Transport :
UN 1170, Class 3, Packing group II
SMILES :
CCCCCC(O) /C=C/[[email protected]] 1C(O) CC(=O) C1C/C=C\CCCC(=O) NCCCCCNC(=O) CCCCC1SCC2NC(=O) NC12

SDS (MSDS) herunterladen

Analysenzertifikat

Um PDF-Dokumente zu Drucken oder zu Bearbeiten
benötigen Sie Adobe Acrobat Reader

  • bvseo_sdk, java_sdk, bvseo-3.2.0
  • CLOUD, getContent, 113ms
  • QUESTIONS, PRODUCT
  • bvseo-msg: The resource to the URL or file is currently unavailable.;
  • bvseo_sdk, java_sdk, bvseo-3.2.0
  • CLOUD, getReviews, 6ms
  • REVIEWS, PRODUCT
  • bvseo-msg: The resource to the URL or file is currently unavailable.;

Santa Cruz Biotechnology, Inc. ist weltweit führend in der Entwicklung von Produkten für den biomedizinischen Forschungsmarkt. Rufen Sie uns an, gebührenfrei unter 00800 4573 8000. .
Copyright © 2007-2021, Santa Cruz Biotechnology, Inc. Alle Rechte vorbehalten. "Santa Cruz Biotechnology", das Santa Cruz Biotechnology, Inc. Logo, "Santa Cruz Animal Health", "San Juan Ranch", "Supplement of Champions", das San Juan Ranch Logo, "Ultracruz", "Chemcruz", "Immunocruz", "Exactacruz" und "EZ Touch" sind eingetragene Warenzeichen der Santa Cruz Biotechnology, Inc. Alle genannte Warenzeichen sind Eigentum der jeweiligen Inhaber. Alle Rechte vorbehalten.